Tryptamine Therapeutics (ASX:TYP) Accounts Payable & Accrued Expense : A$0.31 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Tryptamine Therapeutics Accounts Payable & Accrued Expense?

Tryptamine Therapeutics's quarterly accounts payable & accrued expense declined from Dec. 2022 (A$0.83 Mil) to Jun. 2023 (A$0.11 Mil) but then increased from Jun. 2023 (A$0.11 Mil) to Dec. 2023 (A$0.31 Mil).

Tryptamine Therapeutics's annual accounts payable & accrued expense declined from Jun. 2021 (A$0.91 Mil) to Jun. 2022 (A$0.73 Mil) and declined from Jun. 2022 (A$0.73 Mil) to Jun. 2023 (A$0.11 Mil).

Tryptamine Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Tryptamine Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tryptamine Therapeutics Accounts Payable & Accrued Expense Chart

Tryptamine Therapeutics Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.28

0.61

0.91

0.73

0.11

Tryptamine Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial						1.15	0.73	0.83	0.11	0.31

Tryptamine Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Tryptamine Therapeutics (ASX:TYP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tryptamine Therapeutics Ltd (ASX:TYP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124

Website

https://www.exopharm.com

Exopharm Ltd is a biopharmaceutical company that engages in the development of regenerative medicine in Australia. The company is engaged in developing and commercializing exosomes as therapeutic agents. The company operates in one segment namely the research and development of biopharmaceutical drugs. Revenue is generated from Australia.

Tryptamine Therapeutics (ASX:TYP) Headlines

No Headlines